Business · 28/12/2020Updated: 10/17/2026 · 1 min read
FDA Renewal of Cellular, Tissue and Gene Therapies Advisory Committee
Summary
The Food and Drug Administration (FDA) is renewing the Cellular, Tissue and Gene Therapies Advisory Committee for an additional 2 years, with the new charter set to expire on October 28, 2024, at the request of the Commissioner of Food and Drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →